342 DOSE STABILITY OF TAPENTADOL EXTENDED RELEASE AND OXYCODONE CONTROLLED RELEASE IN A ONE-YEAR, RANDOMIZED, OPEN-LABEL, PHASE 3 SAFETY TRIAL IN PATIENTS WITH CHRONIC LOW BACK OR OSTEOARTHRITIS PAIN